EMN Over-Subscribes Pre-Series A Financing, Announces Strategic Investment from dsm-firmeich

Toronto, October 30, 2023 /CNW/ – Enhanced Medical Nutrition, Inc. (EMN) has announced the successful closing of an oversubscribed pre-Series A equity financing backed by dsm-firmenich venturing, The Kale Fund, Keiretsu Forum and various angel investors. The financing comes as EMN expands to more than 150 orthopedic providers. The proceeds of the transaction will be used to fund EMN’s operations and growth.

EMN is a transformational food-as-medicine company with a mission to improve outcomes in surgery with nutrition. There are about 50 million surgeries. North America Every year and 50% of these procedures include patients who are malnourished and not ready for physical stress. The company markets an evidence-based nutrition program to help patients better prepare and recover faster from surgery. EMN’s initial focus is on orthopedic surgery, and it is conducting extensive clinical research with plans to expand into cardiac and cancer surgeries.

“Every patient has a goal, whether it’s to return to the comfort of their home, regain their independence, return to work, or return to a healthy and active lifestyle. That’s our motivation. Grow our team, expand our reach, and ultimately serve more surgical patients. To our team, clinical partners and investors in us Thank you for believing and supporting our mission. Eric ZimmermanCEO and co-founder of EMN.

Food-as-medicine is a new frontier in healthcare with new and innovative treatment options. Therapeutic foods, functional foods, and customized foods provide patients with a means to proactively prevent and treat health conditions.

About Enhanced Medical Nutrition (EMN):
EMN is a transformational food-as-medicine company with a mission to improve outcomes in surgery with nutrition. The company develops medical food products for patients to be better prepared and recover faster from surgery and serious illness. www.emn.health.

About dsm-firmeich Venturing:
dsm-firmeich Venturing is the corporate venture arm of dsm-firmeich. As innovators in nutrition, health and beauty, dsm-firmeich innovates, produces and combines valuable ingredients, flavors and fragrances to enrich the world’s growing population. With a comprehensive range of solutions based on natural and renewable materials and renowned science and technology capabilities, dsm-firmeich works to create what is essential to life, desirable for consumers and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company listed on Euronext Amsterdam, with operations in nearly 60 countries and revenues of more than 12 billion euros. With a diverse, global team of nearly 30,000 employees, dsm-firmeich brings progress to billions of people every day, everywhere. www.dsm-firmenich.com

About Kale Fund:
Kale Investment Fund LP is an established specialty investment group. Toronto, CanadaIt is renowned for its commitment to fostering innovation in health and safety operations. With a focus on empowering entrepreneurs and high potential, Kale Investment Fund LP leverages its extensive network and expertise to drive sustainable growth, develop transformative ideas and create meaningful impact. www.thekalefund.com

About the Keiretsu Forum:
Keretsu Forum Canada is part of Keretsu Forum, the world’s largest and most active early stage angel investment community. established in California In the year Founded in 2000, the Keiretsu Forum now includes more than 50 chapters in 30 countries worldwide. Invest over Keiretsu Forum 100 million dollars Every year in early stage and growth companies. www.keiretsuforum.ca/

SOURCE Improved medical nutrition



See original content: http://www.newswire.ca/en/releases/archive/October2023/30/c5746.html

Leave a Comment